2 Patents
- US116677222023Antibody That Binds CD269 (BCMA) Suitable for Use in the Treatment of Plasma Cell Diseases Such as Multiple Myeloma and Autoimmune Diseases
Max-delbrück-centrum Für Molekulare Medizin In Der Helmholtz-gemeinschaft
0 cites - US116434682023Chimeric Antigen Receptors and CAR-T Cells That Bind CXCR5 and Methods of Use Thereof to Treat Medical Disorders
Max-delbrück-centrum Für Molekulare Medizin In Der Hemlholtz-gemeinschaft
0 cites